BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15953188)

  • 1. Respiratory vaccination of mice against influenza virus: dissection of T- and B-cell priming functions.
    Coleclough C; Sealy R; Surman S; Marshall DR; Hurwitz JL
    Scand J Immunol; 2005 Jul; 62 Suppl 1():73-83. PubMed ID: 15953188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization.
    Marshall D; Sealy R; Sangster M; Coleclough C
    J Immunol; 1999 Nov; 163(9):4673-82. PubMed ID: 10528164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.
    Wang Z; Chua BY; Ramos JV; Parra SM; Fairmaid E; Brown LE; Jackson DC; Kedzierska K
    Vaccine; 2015 Sep; 33(39):5148-54. PubMed ID: 26277069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells.
    Stevenson PG; Hawke S; Bangham CR
    J Immunol; 1996 Oct; 157(7):3065-73. PubMed ID: 8816416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
    Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
    Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination.
    Surls J; Nazarov-Stoica C; Kehl M; Casares S; Brumeanu TD
    Vaccine; 2010 Oct; 28(45):7319-30. PubMed ID: 20832492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of memory CD8+ T cells with live attenuated influenza virus across different vaccination doses.
    Wang Z; Kedzierski L; Nuessing S; Chua BYL; QuiƱones-Parra SM; Huber VC; Jackson DC; Thomas PG; Kedzierska K
    J Gen Virol; 2016 Dec; 97(12):3205-3214. PubMed ID: 27902386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.
    Liew FY; Russell SM; Appleyard G; Brand CM; Beale J
    Eur J Immunol; 1984 Apr; 14(4):350-6. PubMed ID: 6609824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective antibody responses against A(H1N1)pdm09 primed by infection and recalled by intranasal vaccination.
    Ikeda K; Ainai A; Hasegawa H
    Vaccine; 2015 Nov; 33(45):6066-9. PubMed ID: 26432916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: comparison of formulations and administration routes of vaccines.
    Kashima Y; Ikeda M; Itoh Y; Sakoda Y; Nagata T; Miyake T; Soda K; Ozaki H; Nakayama M; Shibuya H; Okamatsu M; Ishigaki H; Ishida H; Sawai T; Kawaoka Y; Kida H; Ogasawara K
    Vaccine; 2009 Dec; 27(52):7402-8. PubMed ID: 19747993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.
    Bot A; Antohi S; Bot S; Garcia-Sastre A; Bona C
    Int Immunol; 1997 Nov; 9(11):1641-50. PubMed ID: 9418125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.
    Lee YT; Ko EJ; Lee Y; Lee YN; Bian Z; Liu Y; Kang SM
    J Virol; 2016 Aug; 90(15):6746-6758. PubMed ID: 27194758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice.
    Webster RG; Askonas BA
    Eur J Immunol; 1980 May; 10(5):396-401. PubMed ID: 6967815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to influenza infection of mice: different patterns for glycoprotein and nucleocapsid antigens.
    Sealy R; Surman S; Hurwitz JL; Coleclough C
    Immunology; 2003 Apr; 108(4):431-9. PubMed ID: 12667204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
    Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
    Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T
    J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo.
    Garulli B; Di Mario G; Sciaraffia E; Accapezzato D; Barnaba V; Castrucci MR
    Vaccine; 2013 Mar; 31(13):1717-24. PubMed ID: 23380456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.